LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 83

Search options

  1. Article ; Online: Burkholderia pseudomallei and melioidosis.

    Meumann, Ella M / Limmathurotsakul, Direk / Dunachie, Susanna J / Wiersinga, Willem J / Currie, Bart J

    Nature reviews. Microbiology

    2023  Volume 22, Issue 3, Page(s) 155–169

    Abstract: Burkholderia pseudomallei, the causative agent of melioidosis, is found in soil and water of tropical and subtropical regions globally. Modelled estimates of the global burden predict that melioidosis remains vastly under-reported, and a call has been ... ...

    Abstract Burkholderia pseudomallei, the causative agent of melioidosis, is found in soil and water of tropical and subtropical regions globally. Modelled estimates of the global burden predict that melioidosis remains vastly under-reported, and a call has been made for it to be recognized as a neglected tropical disease by the World Health Organization. Severe weather events and environmental disturbance are associated with increased case numbers, and it is anticipated that, in some regions, cases will increase in association with climate change. Genomic epidemiological investigations have confirmed B. pseudomallei endemicity in newly recognized regions, including the southern United States. Melioidosis follows environmental exposure to B. pseudomallei and is associated with comorbidities that affect the immune response, such as diabetes, and with socioeconomic disadvantage. Several vaccine candidates are ready for phase I clinical trials. In this Review, we explore the global burden, epidemiology and pathophysiology of B. pseudomallei as well as current diagnostics, treatment recommendations and preventive measures, highlighting research needs and priorities.
    MeSH term(s) Humans ; Burkholderia pseudomallei/genetics ; Melioidosis/diagnosis ; Melioidosis/epidemiology ; Melioidosis/prevention & control ; Environmental Exposure ; World Health Organization ; Genomics
    Language English
    Publishing date 2023-10-04
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2139054-X
    ISSN 1740-1534 ; 1740-1526
    ISSN (online) 1740-1534
    ISSN 1740-1526
    DOI 10.1038/s41579-023-00972-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria.

    Dunachie, Susanna J / Day, Nicholas Pj / Dolecek, Christiane

    Current opinion in microbiology

    2020  Volume 57, Page(s) 95–101

    Abstract: Estimating the contribution of antimicrobial resistance (AMR) to global mortality and healthcare costs enables evaluation of interventions, informs policy decisions on resource allocation, and drives research priorities. However assembling the high ... ...

    Abstract Estimating the contribution of antimicrobial resistance (AMR) to global mortality and healthcare costs enables evaluation of interventions, informs policy decisions on resource allocation, and drives research priorities. However assembling the high quality, patient-level data required for global estimates is challenging. Capacity for accurate microbiology culture and antimicrobial susceptibility testing is woefully neglected in low and middle-income countries, and further surveillance and research on community antimicrobial usage, bias in blood culture sampling, and the contribution of co-morbidities such as diabetes is essential. International collaboration between governments, policy makers, academics, microbiologists, front-line clinicians, veterinarians, the food and agriculture industry and the public is critical to understand and tackle AMR.
    MeSH term(s) Animals ; Anti-Bacterial Agents/pharmacology ; Bacteria/drug effects ; Bacteria/genetics ; Bacteria/metabolism ; Bacterial Infections/drug therapy ; Bacterial Infections/microbiology ; Drug Resistance, Bacterial ; Global Burden of Disease ; Humans
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2020-11-02
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1418474-6
    ISSN 1879-0364 ; 1369-5274
    ISSN (online) 1879-0364
    ISSN 1369-5274
    DOI 10.1016/j.mib.2020.09.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria

    Dunachie, Susanna J / Day, Nicholas PJ / Dolecek, Christiane

    Current opinion in microbiology. 2020 Oct., v. 57

    2020  

    Abstract: Estimating the contribution of antimicrobial resistance (AMR) to global mortality and healthcare costs enables evaluation of interventions, informs policy decisions on resource allocation, and drives research priorities. However assembling the high ... ...

    Abstract Estimating the contribution of antimicrobial resistance (AMR) to global mortality and healthcare costs enables evaluation of interventions, informs policy decisions on resource allocation, and drives research priorities. However assembling the high quality, patient-level data required for global estimates is challenging. Capacity for accurate microbiology culture and antimicrobial susceptibility testing is woefully neglected in low and middle-income countries, and further surveillance and research on community antimicrobial usage, bias in blood culture sampling, and the contribution of co-morbidities such as diabetes is essential. International collaboration between governments, policy makers, academics, microbiologists, front-line clinicians, veterinarians, the food and agriculture industry and the public is critical to understand and tackle AMR.
    Keywords agricultural industry ; antibiotic resistance ; blood ; burden of disease ; diabetes ; humans ; issues and policy ; monitoring ; mortality ; resource allocation
    Language English
    Dates of publication 2020-10
    Size p. 95-101.
    Publishing place Elsevier Ltd
    Document type Article
    Note NAL-AP-2-clean
    ZDB-ID 1418474-6
    ISSN 1879-0364 ; 1369-5274
    ISSN (online) 1879-0364
    ISSN 1369-5274
    DOI 10.1016/j.mib.2020.09.013
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: T cell immune memory after covid-19 and vaccination.

    Wang, Lulu / Nicols, Alex / Turtle, Lance / Richter, Alex / Duncan, Christopher Ja / Dunachie, Susanna J / Klenerman, Paul / Payne, Rebecca P

    BMJ medicine

    2023  Volume 2, Issue 1, Page(s) e000468

    Abstract: The T cell memory response is a crucial component of adaptive immunity responsible for limiting or preventing viral reinfection. T cell memory after infection with the SARS-CoV-2 virus or vaccination is broad, and spans multiple viral proteins and ... ...

    Abstract The T cell memory response is a crucial component of adaptive immunity responsible for limiting or preventing viral reinfection. T cell memory after infection with the SARS-CoV-2 virus or vaccination is broad, and spans multiple viral proteins and epitopes, about 20 in each individual. So far the T cell memory response is long lasting and provides a high level of cross reactivity and hence resistance to viral escape by variants of the SARS-CoV-2 virus, such as the omicron variant. All current vaccine regimens tested produce robust T cell memory responses, and heterologous regimens will probably enhance protective responses through increased breadth. T cell memory could have a major role in protecting against severe covid-19 disease through rapid viral clearance and early presentation of epitopes, and the presence of cross reactive T cells might enhance this protection. T cell memory is likely to provide ongoing protection against admission to hospital and death, and the development of a pan-coronovirus vaccine might future proof against new pandemic strains.
    Language English
    Publishing date 2023-11-22
    Publishing country England
    Document type Journal Article ; Review
    ISSN 2754-0413
    ISSN (online) 2754-0413
    DOI 10.1136/bmjmed-2022-000468
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records.

    Doran, William / Tunnicliffe, Louis / Muzambi, Rutendo / Rentsch, Christopher T / Bhaskaran, Krishnan / Smeeth, Liam / Brayne, Carol / Williams, Dylan M / Chaturvedi, Nish / Eastwood, Sophie V / Dunachie, Susanna J / Mathur, Rohini / Warren-Gash, Charlotte

    BMJ open diabetes research & care

    2024  Volume 12, Issue 1

    Abstract: Introduction: 4.2 million individuals in the UK have type 2 diabetes, a known risk factor for dementia and mild cognitive impairment (MCI). Diabetes treatment may modify this association, but existing evidence is conflicting. We therefore aimed to ... ...

    Abstract Introduction: 4.2 million individuals in the UK have type 2 diabetes, a known risk factor for dementia and mild cognitive impairment (MCI). Diabetes treatment may modify this association, but existing evidence is conflicting. We therefore aimed to assess the association between metformin therapy and risk of incident all-cause dementia or MCI compared with other oral glucose-lowering therapies (GLTs).
    Research design and methods: We conducted an observational cohort study using the Clinical Practice Research Datalink among UK adults diagnosed with diabetes at ≥40 years between 1990 and 2019. We used an active comparator new user design to compare risks of dementia and MCI among individuals initially prescribed metformin versus an alternative oral GLT using Cox proportional hazards regression controlling for sociodemographic, lifestyle and clinical confounders. We assessed for interaction by age and sex. Sensitivity analyses included an as-treated analysis to mitigate potential exposure misclassification.
    Results: We included 211 396 individuals (median age 63 years; 42.8% female), of whom 179 333 (84.8%) initiated on metformin therapy. Over median follow-up of 5.4 years, metformin use was associated with a lower risk of dementia (adjusted HR (aHR) 0.86 (95% CI 0.79 to 0.94)) and MCI (aHR 0.92 (95% CI 0.86 to 0.99)). Metformin users aged under 80 years had a lower dementia risk (aHR 0.77 (95% CI 0.68 to 0.85)), which was not observed for those aged ≥80 years (aHR 0.95 (95% CI 0.87 to 1.05)). There was no interaction with sex. The as-treated analysis showed a reduced effect size compared with the main analysis (aHR 0.90 (95% CI 0.83 to 0.98)).
    Conclusions: Metformin use was associated with lower risks of incident dementia and MCI compared with alternative GLT among UK adults with diabetes. While our findings are consistent with a neuroprotective effect of metformin against dementia, further research is needed to reduce risks of confounding by indication and assess causality.
    MeSH term(s) Adult ; Humans ; Female ; Middle Aged ; Male ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/epidemiology ; Metformin/adverse effects ; Cohort Studies ; Hypoglycemic Agents/adverse effects ; Glucose ; Dementia/epidemiology ; Dementia/prevention & control ; Primary Health Care ; United Kingdom/epidemiology
    Chemical Substances Metformin (9100L32L2N) ; Hypoglycemic Agents ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2024-01-25
    Publishing country England
    Document type Observational Study ; Journal Article
    ZDB-ID 2732918-5
    ISSN 2052-4897 ; 2052-4897
    ISSN (online) 2052-4897
    ISSN 2052-4897
    DOI 10.1136/bmjdrc-2023-003548
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.

    Zhou, Daming / Supasa, Piyada / Liu, Chang / Dijokaite-Guraliuc, Aiste / Duyvesteyn, Helen M E / Selvaraj, Muneeswaran / Mentzer, Alexander J / Das, Raksha / Dejnirattisai, Wanwisa / Temperton, Nigel / Klenerman, Paul / Dunachie, Susanna J / Fry, Elizabeth E / Mongkolsapaya, Juthathip / Ren, Jingshan / Stuart, David I / Screaton, Gavin R

    Nature communications

    2024  Volume 15, Issue 1, Page(s) 2734

    Abstract: Under pressure from neutralising antibodies induced by vaccination or infection the SARS-CoV-2 spike gene has become a hotspot for evolutionary change, leading to the failure of all mAbs developed for clinical use. Most potent antibodies bind to the ... ...

    Abstract Under pressure from neutralising antibodies induced by vaccination or infection the SARS-CoV-2 spike gene has become a hotspot for evolutionary change, leading to the failure of all mAbs developed for clinical use. Most potent antibodies bind to the receptor binding domain which has become heavily mutated. Here we study responses to a conserved epitope in sub-domain-1 (SD1) of spike which have become more prominent because of mutational escape from antibodies directed to the receptor binding domain. Some SD1 reactive mAbs show potent and broad neutralization of SARS-CoV-2 variants. We structurally map the dominant SD1 epitope and provide a mechanism of action by blocking interaction with ACE2. Mutations in SD1 have not been sustained to date, but one, E554K, leads to escape from mAbs. This mutation has now emerged in several sublineages including BA.2.86, reflecting selection pressure on the virus exerted by the increasing prominence of the anti-SD1 response.
    MeSH term(s) Humans ; Antibodies, Neutralizing ; SARS-CoV-2/genetics ; COVID-19 ; Antibodies, Monoclonal ; Epitopes ; Spike Glycoprotein, Coronavirus/genetics ; Antibodies, Viral ; Syndactyly
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Monoclonal ; Epitopes ; Spike Glycoprotein, Coronavirus ; Antibodies, Viral ; spike protein, SARS-CoV-2
    Language English
    Publishing date 2024-03-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-024-46982-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Identification and function of a novel human memory-like NK cell population expressing CD160 in melioidosis.

    Preechanukul, Anucha / Kronsteiner, Barbara / Saiprom, Natnaree / Rochaikun, Kitilak / Moonmueangsan, Boonthanom / Phunpang, Rungnapa / Ottiwet, Orawan / Kongphrai, Yuphin / Wapee, Soonthon / Chotivanich, Kesinee / Morakot, Chumpol / Janon, Rachan / Dunachie, Susanna J / Chantratita, Narisara

    iScience

    2023  Volume 26, Issue 8, Page(s) 107234

    Abstract: NK cells are endowed with immunological memory to a range of pathogens but the development of NK cell memory in bacterial infections remains elusive. Here, we establish an assay inducing memory-like NK cell response ... ...

    Abstract NK cells are endowed with immunological memory to a range of pathogens but the development of NK cell memory in bacterial infections remains elusive. Here, we establish an assay inducing memory-like NK cell response to
    Language English
    Publishing date 2023-06-28
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2023.107234
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A whole blood intracellular cytokine assay optimised for field site studies demonstrates polyfunctionality of CD4+ T cells in acute scrub typhus.

    Inthawong, Manutsanun / Pinthong, Nattapon / Thaiprakhong, Areerat / Wangrangsimakul, Tri / Sunyakumthorn, Piyanate / Hill, Jennifer / Sonthayanon, Piengchan / Paris, Daniel H / Dunachie, Susanna J / Kronsteiner, Barbara

    PLoS neglected tropical diseases

    2023  Volume 17, Issue 3, Page(s) e0010905

    Abstract: Background: Assessment of cellular immune responses by combining intracellular cytokine staining and immunophenotyping using flow cytometry enables the simultaneous measurement of T cell phenotype and effector function in response to pathogens and ... ...

    Abstract Background: Assessment of cellular immune responses by combining intracellular cytokine staining and immunophenotyping using flow cytometry enables the simultaneous measurement of T cell phenotype and effector function in response to pathogens and vaccines. The use of whole blood samples rather than peripheral blood mononuclear cells avoids both the need for immediate processing and loss of functional antigen presenting cells due to processing and cryopreservation. Using whole blood provides the possibility to stimulate peripheral T cells in situ, and is more suitable for studies where sample volume is limited, such as those involving children, the elderly and critically ill patients. The aim of this study was to provide a robust tool for the assessment of antigen-specific T cell responses in a field site setting with limited resources.
    Methodology/principle findings: We optimised a flow cytometry-based whole blood intracellular cytokine assay (WBA) with respect to duration of antigen stimulation and intracellular protein retention time. We demonstrate the ability of the WBA to capture polyfunctional T cell responses in the context of acute scrub typhus infection, by measuring IFN-γ, TNF and IL-2 in CD4+ and CD8+ T cells in response to the causative agent O. tsutsugamushi (OT). Using an optimised OT antigen preparation, we demonstrate the presence of polyfunctional antigen-specific memory CD4+ T cells in the blood of scrub typhus patients.
    Conclusions/significance: In conclusion, this flow cytometry-based WBA is well-suited for use at field study sites, and enables the assessment of polyfunctional T cell responses to infectious agents and vaccines through delineation of antigen-specific cytokine secretion at the single cell level.
    MeSH term(s) Humans ; Scrub Typhus ; CD4-Positive T-Lymphocytes ; Leukocytes, Mononuclear ; CD8-Positive T-Lymphocytes ; Cytokines
    Chemical Substances Cytokines
    Language English
    Publishing date 2023-03-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2429704-5
    ISSN 1935-2735 ; 1935-2735
    ISSN (online) 1935-2735
    ISSN 1935-2735
    DOI 10.1371/journal.pntd.0010905
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Dynamic mitochondrial transcription and translation in B cells control germinal center entry and lymphomagenesis.

    Yazicioglu, Yavuz F / Marin, Eros / Sandhu, Ciaran / Galiani, Silvia / Raza, Iwan G A / Ali, Mohammad / Kronsteiner, Barbara / Compeer, Ewoud B / Attar, Moustafa / Dunachie, Susanna J / Dustin, Michael L / Clarke, Alexander J

    Nature immunology

    2023  Volume 24, Issue 6, Page(s) 991–1006

    Abstract: Germinal center (GC) B cells undergo proliferation at very high rates in a hypoxic microenvironment but the cellular processes driving this are incompletely understood. Here we show that the mitochondria of GC B cells are highly dynamic, with ... ...

    Abstract Germinal center (GC) B cells undergo proliferation at very high rates in a hypoxic microenvironment but the cellular processes driving this are incompletely understood. Here we show that the mitochondria of GC B cells are highly dynamic, with significantly upregulated transcription and translation rates associated with the activity of transcription factor A, mitochondrial (TFAM). TFAM, while also necessary for normal B cell development, is required for entry of activated GC precursor B cells into the germinal center reaction; deletion of Tfam significantly impairs GC formation, function and output. Loss of TFAM in B cells compromises the actin cytoskeleton and impairs cellular motility of GC B cells in response to chemokine signaling, leading to their spatial disorganization. We show that B cell lymphoma substantially increases mitochondrial translation and that deletion of Tfam in B cells is protective against the development of lymphoma in a c-Myc transgenic mouse model. Finally, we show that pharmacological inhibition of mitochondrial transcription and translation inhibits growth of GC-derived human lymphoma cells and induces similar defects in the actin cytoskeleton.
    MeSH term(s) Mice ; Humans ; Animals ; B-Lymphocytes/pathology ; Germinal Center/pathology ; Transcription, Genetic ; Lymphoma, B-Cell/genetics ; Lymphoma, B-Cell/pathology ; Lymphoma ; Mice, Transgenic ; Tumor Microenvironment
    Language English
    Publishing date 2023-04-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2016987-5
    ISSN 1529-2916 ; 1529-2908
    ISSN (online) 1529-2916
    ISSN 1529-2908
    DOI 10.1038/s41590-023-01484-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Deciphering the human antibody response against

    Wagner, Gabriel E / Stanjek, Thomas Franz Paul / Albrecht, Dirk / Lipp, Michaela / Dunachie, Susanna J / Föderl-Höbenreich, Esther / Riedel, Katharina / Kohler, Anne / Steinmetz, Ivo / Kohler, Christian

    Frontiers in immunology

    2023  Volume 14, Page(s) 1294113

    Abstract: Introduction: The environmental bacterium : Methods and results: In this study, : Conclusion: Our study shows that a ... ...

    Abstract Introduction: The environmental bacterium
    Methods and results: In this study,
    Conclusion: Our study shows that a comprehensive
    MeSH term(s) Humans ; Burkholderia pseudomallei ; Melioidosis ; Antibody Formation ; Antigens, Bacterial ; Immunoglobulins
    Chemical Substances Antigens, Bacterial ; Immunoglobulins
    Language English
    Publishing date 2023-12-11
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1294113
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top